×
About 135,870 results

ALLMedicine™ Schizophrenia Center

Research & Reviews  65,551 results

Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development.
https://doi.org/10.1016/j.schres.2020.09.013
Schizophrenia Research; Egerton A, Grace AA et. al.

Oct 19th, 2020 - Research into the neurobiological processes that may lead to the onset of schizophrenia places growing emphasis on the glutamatergic system and brain development. Preclinical studies have shown that neurodevelopmental, genetic, and environmental f...

The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in ...
https://doi.org/10.1016/j.schres.2020.08.008
Schizophrenia Research; Goldring A, Borne S et. al.

Oct 19th, 2020 - Clinician-administered measures of negative symptoms may not capture patients' subjective experiences. The Self-Evaluation of Negative Symptoms (SNS) has shown good psychometric properties when used in outpatients with higher-level functioning sch...

Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders:...
https://doi.org/10.1017/S0033291720003670
Psychological Medicine; Begemann MJ, Brand BA et. al.

Oct 19th, 2020 - Cognition is commonly affected in brain disorders. Non-invasive brain stimulation (NIBS) may have procognitive effects, with high tolerability. This meta-analysis evaluates the efficacy of transcranial magnetic stimulation (TMS) and transcranial D...

Evidence, and replication thereof, that molecular-genetic and environmental risks for p...
https://doi.org/10.1017/S0033291720003748
Psychological Medicine; van Os J, Pries LK et. al.

Oct 19th, 2020 - There is evidence that environmental and genetic risk factors for schizophrenia spectrum disorders are transdiagnostic and mediated in part through a generic pathway of affective dysregulation. We analysed to what degree the impact of schizophreni...

Targeting affect leads to reduced paranoia in people with psychosis: a single case series.
https://doi.org/10.1017/S1352465820000788
Behavioural and Cognitive Psychotherapy; Silva D, Maguire T et. al.

Oct 19th, 2020 - Current psychological interventions for psychosis focus primarily on cognitive and behavioural management of delusions and hallucinations, with modest outcomes. Emotions are not usually targeted directly, despite evidence that people with psychosi...

see more →

Guidelines  43 results

The American Psychiatric Association Practice Guideline for the Treatment of Patients W...
https://doi.org/10.1176/appi.ajp.2020.177901
The American Journal of Psychiatry; Keepers GA, Fochtmann LJ et. al.

Sep 1st, 2020 - The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.|2020|Keepers GA,Fochtmann LJ,Anzia JM,Benjamin S,Lyness JM,|methods,methods,methods,classification,therapeutic use,diagnosis,therapy,

CAPLYTA® (lumateperone) | Now Approved | caplyta.com‎
https://www.caplyta.com/‎

Jan 13th, 2020 - Learn about a new treatment. See full safety information, PI, and boxed warning. Get information about this orally administered capsule. Press Release. Prescribing Information. MOA. Important Safety Info. Dosing & Administration.

Cannabidiol as a potential treatment for psychosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843725/
Therapeutic Advances in Psychopharmacology; Davies C,et al

Nov 7th, 2019 - Psychotic disorders such as schizophrenia are heterogeneous and often debilitating conditions that contribute substantially to the global burden of disease. The introduction of dopamine D2 receptor antagonists in the 1950s revolutionised the treat...

U.S. FDA Approves SECUADO® (asenapine) Transdermal System, the First-and-Only Transdermal Patch for the Treatment of Adults with Schizophrenia
http://www.noven.com/PR101519.php

Oct 14th, 2019 - Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S. Food and Drug Administration (FDA) has approved SECUADO® (asenapine) transdermal system, the first-and-only transdermal patch fo...

HIV, schizophrenia, and all-cause mortality
https://www.sciencedirect.com/science/article/abs/pii/S0920996419301537?via%3Dihub
Schizophrenia Research;

Jun 26th, 2019 - Schizophrenia is a severe mental illness with important implications for morbidity and mortality. This population-based cohort study examined the impact of schizophrenia diagnoses on all-cause mortality among a sample of people living with HIV (PL...

see more →

Drugs  1,519 results see all →

Clinicaltrials.gov  67,357 results

Quetiapine fumarate - quetiapine tablet-BluePoint Laboratories
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=874e50ad-5da0-4ac3-9290-79442c91399e

Oct 31st, 2020 - Quetiapine tablet USP is an atypical antipsychotic indicated for the treatment of: • Schizophrenia (1.1) •  Bipolar I disorder manic episodes (1.2) •  Bipolar disorder, depressive episodes (1.2) Quetiapine tablets USP are indicated for the treatme...

Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development.
https://doi.org/10.1016/j.schres.2020.09.013
Schizophrenia Research; Egerton A, Grace AA et. al.

Oct 19th, 2020 - Research into the neurobiological processes that may lead to the onset of schizophrenia places growing emphasis on the glutamatergic system and brain development. Preclinical studies have shown that neurodevelopmental, genetic, and environmental f...

The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in ...
https://doi.org/10.1016/j.schres.2020.08.008
Schizophrenia Research; Goldring A, Borne S et. al.

Oct 19th, 2020 - Clinician-administered measures of negative symptoms may not capture patients' subjective experiences. The Self-Evaluation of Negative Symptoms (SNS) has shown good psychometric properties when used in outpatients with higher-level functioning sch...

Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders:...
https://doi.org/10.1017/S0033291720003670
Psychological Medicine; Begemann MJ, Brand BA et. al.

Oct 19th, 2020 - Cognition is commonly affected in brain disorders. Non-invasive brain stimulation (NIBS) may have procognitive effects, with high tolerability. This meta-analysis evaluates the efficacy of transcranial magnetic stimulation (TMS) and transcranial D...

Evidence, and replication thereof, that molecular-genetic and environmental risks for p...
https://doi.org/10.1017/S0033291720003748
Psychological Medicine; van Os J, Pries LK et. al.

Oct 19th, 2020 - There is evidence that environmental and genetic risk factors for schizophrenia spectrum disorders are transdiagnostic and mediated in part through a generic pathway of affective dysregulation. We analysed to what degree the impact of schizophreni...

see more →

News  1,361 results

Minerva's schizophrenia drug misses main goal in study; shares tumble
https://www.reuters.com/article/us-minerva-study/minervas-schizophrenia-drug-misses-main-goal-in-study-shares-tumble-idUSKBN23521L

May 29th, 2020 - (Reuters) - Drug developer Minerva Neurosciences Inc said on Friday its experimental drug for schizophrenia did not meet the main goal of a late-stage study, sending its shares down nearly 66% in early trade. The drug, roluperidone, did not show s...

Is psychosis toxic to the brain?
https://www.mdedge.com/psychiatry/article/219773/schizophrenia-other-psychotic-disorders/psychosis-toxic-brain?channel=133
Gerald Martone, MS, MSN, PMHNP-BC

Mar 31st, 2020 - Schizophrenia has been described as the “worst disease” to afflict mankind. 1 It causes psychosis, which is an abnormal state of mind marked by hyperarousal, overactivation of brain circuits, and emotional distress.

Paradise lost: Life, liberty, and the pursuit of happiness among psychiatric patients
https://www.mdedge.com/psychiatry/article/217949/paradise-lost-life-liberty-and-pursuit-happiness-among-psychiatric/page/0/1?channel=41022

Mar 2nd, 2020 - Happiness. I often wonder if most Americans these days are pursuing pleasure rather than happiness, seeking the momentary thrill and gratification instead of long-lasting happiness and joy.

Severe infection tied to substance-induced psychosis, conversion to schizophrenia
https://www.mdedge.com/psychiatry/article/217686/schizophrenia-other-psychotic-disorders/severe-infection-tied-substance/page/0/1?channel=293

Feb 22nd, 2020 - Interpret with caution Commenting on the study, Ole Köhler-Forsberg, MD, from the Psychosis Research Unit, Aarhus University Hospital, Denmark, said in an interview that the findings support a potential immunologic link to schizophrenia. “However,.

see more →

Patient Education  39 results see all →